Medical Care
Global CD Targeted Bispecific Antibody Market Research Report 2025
- May 12, 25
- ID: 236263
- Pages: 82
- Figures: 86
- Views: 1
The global market for CD Targeted Bispecific Antibody was valued at US$ 6085 million in the year 2024 and is projected to reach a revised size of US$ 11390 million by 2031, growing at a CAGR of 9.5% during the forecast period.
A CD-targeted bispecific antibody refers to a type of bispecific antibody designed to target specific cell surface markers known as cluster of differentiation (CD) antigens. Bispecific antibodies are engineered proteins that can simultaneously bind to two different antigens, often on distinct cell types. These antibodies have gained attention for their potential therapeutic applications, including cancer immunotherapy.
Researchers are exploring a broader range of target antigens beyond well-established CD antigens. This includes identifying new cell surface markers specific to certain cancers or disease types, providing additional options for targeted therapies.
This report aims to provide a comprehensive presentation of the global market for CD Targeted Bispecific Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD Targeted Bispecific Antibody.
The CD Targeted Bispecific Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD Targeted Bispecific Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD Targeted Bispecific Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aptevo Therapeutics
Affimed Gmbh
Sutro Biopharma
Igm Biosciences
Xencor
Amgen
Genentech Usa
Astella Pharma
Ben Kang Biopharmaceutical (Shenzhen)
Merus
Regeneron Pharmaceuticals
Segment by Type
CD3
CD20
CD40
Others
Segment by Application
Biotechnology
Laboratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CD Targeted Bispecific Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A CD-targeted bispecific antibody refers to a type of bispecific antibody designed to target specific cell surface markers known as cluster of differentiation (CD) antigens. Bispecific antibodies are engineered proteins that can simultaneously bind to two different antigens, often on distinct cell types. These antibodies have gained attention for their potential therapeutic applications, including cancer immunotherapy.
Researchers are exploring a broader range of target antigens beyond well-established CD antigens. This includes identifying new cell surface markers specific to certain cancers or disease types, providing additional options for targeted therapies.
This report aims to provide a comprehensive presentation of the global market for CD Targeted Bispecific Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CD Targeted Bispecific Antibody.
The CD Targeted Bispecific Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CD Targeted Bispecific Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CD Targeted Bispecific Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aptevo Therapeutics
Affimed Gmbh
Sutro Biopharma
Igm Biosciences
Xencor
Amgen
Genentech Usa
Astella Pharma
Ben Kang Biopharmaceutical (Shenzhen)
Merus
Regeneron Pharmaceuticals
Segment by Type
CD3
CD20
CD40
Others
Segment by Application
Biotechnology
Laboratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CD Targeted Bispecific Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD Targeted Bispecific Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CD3
1.2.3 CD20
1.2.4 CD40
1.2.5 Others
1.3 Market by Application
1.3.1 Global CD Targeted Bispecific Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD Targeted Bispecific Antibody Market Perspective (2020-2031)
2.2 Global CD Targeted Bispecific Antibody Growth Trends by Region
2.2.1 Global CD Targeted Bispecific Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CD Targeted Bispecific Antibody Historic Market Size by Region (2020-2025)
2.2.3 CD Targeted Bispecific Antibody Forecasted Market Size by Region (2026-2031)
2.3 CD Targeted Bispecific Antibody Market Dynamics
2.3.1 CD Targeted Bispecific Antibody Industry Trends
2.3.2 CD Targeted Bispecific Antibody Market Drivers
2.3.3 CD Targeted Bispecific Antibody Market Challenges
2.3.4 CD Targeted Bispecific Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD Targeted Bispecific Antibody Players by Revenue
3.1.1 Global Top CD Targeted Bispecific Antibody Players by Revenue (2020-2025)
3.1.2 Global CD Targeted Bispecific Antibody Revenue Market Share by Players (2020-2025)
3.2 Global CD Targeted Bispecific Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CD Targeted Bispecific Antibody Revenue
3.4 Global CD Targeted Bispecific Antibody Market Concentration Ratio
3.4.1 Global CD Targeted Bispecific Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD Targeted Bispecific Antibody Revenue in 2024
3.5 Global Key Players of CD Targeted Bispecific Antibody Head office and Area Served
3.6 Global Key Players of CD Targeted Bispecific Antibody, Product and Application
3.7 Global Key Players of CD Targeted Bispecific Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CD Targeted Bispecific Antibody Breakdown Data by Type
4.1 Global CD Targeted Bispecific Antibody Historic Market Size by Type (2020-2025)
4.2 Global CD Targeted Bispecific Antibody Forecasted Market Size by Type (2026-2031)
5 CD Targeted Bispecific Antibody Breakdown Data by Application
5.1 Global CD Targeted Bispecific Antibody Historic Market Size by Application (2020-2025)
5.2 Global CD Targeted Bispecific Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CD Targeted Bispecific Antibody Market Size (2020-2031)
6.2 North America CD Targeted Bispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CD Targeted Bispecific Antibody Market Size by Country (2020-2025)
6.4 North America CD Targeted Bispecific Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD Targeted Bispecific Antibody Market Size (2020-2031)
7.2 Europe CD Targeted Bispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CD Targeted Bispecific Antibody Market Size by Country (2020-2025)
7.4 Europe CD Targeted Bispecific Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CD Targeted Bispecific Antibody Market Size (2020-2031)
8.2 Asia-Pacific CD Targeted Bispecific Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CD Targeted Bispecific Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific CD Targeted Bispecific Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CD Targeted Bispecific Antibody Market Size (2020-2031)
9.2 Latin America CD Targeted Bispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CD Targeted Bispecific Antibody Market Size by Country (2020-2025)
9.4 Latin America CD Targeted Bispecific Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD Targeted Bispecific Antibody Market Size (2020-2031)
10.2 Middle East & Africa CD Targeted Bispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CD Targeted Bispecific Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa CD Targeted Bispecific Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aptevo Therapeutics
11.1.1 Aptevo Therapeutics Company Details
11.1.2 Aptevo Therapeutics Business Overview
11.1.3 Aptevo Therapeutics CD Targeted Bispecific Antibody Introduction
11.1.4 Aptevo Therapeutics Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.1.5 Aptevo Therapeutics Recent Development
11.2 Affimed Gmbh
11.2.1 Affimed Gmbh Company Details
11.2.2 Affimed Gmbh Business Overview
11.2.3 Affimed Gmbh CD Targeted Bispecific Antibody Introduction
11.2.4 Affimed Gmbh Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.2.5 Affimed Gmbh Recent Development
11.3 Sutro Biopharma
11.3.1 Sutro Biopharma Company Details
11.3.2 Sutro Biopharma Business Overview
11.3.3 Sutro Biopharma CD Targeted Bispecific Antibody Introduction
11.3.4 Sutro Biopharma Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.3.5 Sutro Biopharma Recent Development
11.4 Igm Biosciences
11.4.1 Igm Biosciences Company Details
11.4.2 Igm Biosciences Business Overview
11.4.3 Igm Biosciences CD Targeted Bispecific Antibody Introduction
11.4.4 Igm Biosciences Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.4.5 Igm Biosciences Recent Development
11.5 Xencor
11.5.1 Xencor Company Details
11.5.2 Xencor Business Overview
11.5.3 Xencor CD Targeted Bispecific Antibody Introduction
11.5.4 Xencor Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.5.5 Xencor Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen CD Targeted Bispecific Antibody Introduction
11.6.4 Amgen Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Genentech Usa
11.7.1 Genentech Usa Company Details
11.7.2 Genentech Usa Business Overview
11.7.3 Genentech Usa CD Targeted Bispecific Antibody Introduction
11.7.4 Genentech Usa Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.7.5 Genentech Usa Recent Development
11.8 Astella Pharma
11.8.1 Astella Pharma Company Details
11.8.2 Astella Pharma Business Overview
11.8.3 Astella Pharma CD Targeted Bispecific Antibody Introduction
11.8.4 Astella Pharma Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.8.5 Astella Pharma Recent Development
11.9 Ben Kang Biopharmaceutical (Shenzhen)
11.9.1 Ben Kang Biopharmaceutical (Shenzhen) Company Details
11.9.2 Ben Kang Biopharmaceutical (Shenzhen) Business Overview
11.9.3 Ben Kang Biopharmaceutical (Shenzhen) CD Targeted Bispecific Antibody Introduction
11.9.4 Ben Kang Biopharmaceutical (Shenzhen) Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.9.5 Ben Kang Biopharmaceutical (Shenzhen) Recent Development
11.10 Merus
11.10.1 Merus Company Details
11.10.2 Merus Business Overview
11.10.3 Merus CD Targeted Bispecific Antibody Introduction
11.10.4 Merus Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.10.5 Merus Recent Development
11.11 Regeneron Pharmaceuticals
11.11.1 Regeneron Pharmaceuticals Company Details
11.11.2 Regeneron Pharmaceuticals Business Overview
11.11.3 Regeneron Pharmaceuticals CD Targeted Bispecific Antibody Introduction
11.11.4 Regeneron Pharmaceuticals Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.11.5 Regeneron Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD Targeted Bispecific Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CD3
1.2.3 CD20
1.2.4 CD40
1.2.5 Others
1.3 Market by Application
1.3.1 Global CD Targeted Bispecific Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD Targeted Bispecific Antibody Market Perspective (2020-2031)
2.2 Global CD Targeted Bispecific Antibody Growth Trends by Region
2.2.1 Global CD Targeted Bispecific Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CD Targeted Bispecific Antibody Historic Market Size by Region (2020-2025)
2.2.3 CD Targeted Bispecific Antibody Forecasted Market Size by Region (2026-2031)
2.3 CD Targeted Bispecific Antibody Market Dynamics
2.3.1 CD Targeted Bispecific Antibody Industry Trends
2.3.2 CD Targeted Bispecific Antibody Market Drivers
2.3.3 CD Targeted Bispecific Antibody Market Challenges
2.3.4 CD Targeted Bispecific Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CD Targeted Bispecific Antibody Players by Revenue
3.1.1 Global Top CD Targeted Bispecific Antibody Players by Revenue (2020-2025)
3.1.2 Global CD Targeted Bispecific Antibody Revenue Market Share by Players (2020-2025)
3.2 Global CD Targeted Bispecific Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CD Targeted Bispecific Antibody Revenue
3.4 Global CD Targeted Bispecific Antibody Market Concentration Ratio
3.4.1 Global CD Targeted Bispecific Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD Targeted Bispecific Antibody Revenue in 2024
3.5 Global Key Players of CD Targeted Bispecific Antibody Head office and Area Served
3.6 Global Key Players of CD Targeted Bispecific Antibody, Product and Application
3.7 Global Key Players of CD Targeted Bispecific Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CD Targeted Bispecific Antibody Breakdown Data by Type
4.1 Global CD Targeted Bispecific Antibody Historic Market Size by Type (2020-2025)
4.2 Global CD Targeted Bispecific Antibody Forecasted Market Size by Type (2026-2031)
5 CD Targeted Bispecific Antibody Breakdown Data by Application
5.1 Global CD Targeted Bispecific Antibody Historic Market Size by Application (2020-2025)
5.2 Global CD Targeted Bispecific Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CD Targeted Bispecific Antibody Market Size (2020-2031)
6.2 North America CD Targeted Bispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CD Targeted Bispecific Antibody Market Size by Country (2020-2025)
6.4 North America CD Targeted Bispecific Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CD Targeted Bispecific Antibody Market Size (2020-2031)
7.2 Europe CD Targeted Bispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CD Targeted Bispecific Antibody Market Size by Country (2020-2025)
7.4 Europe CD Targeted Bispecific Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CD Targeted Bispecific Antibody Market Size (2020-2031)
8.2 Asia-Pacific CD Targeted Bispecific Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CD Targeted Bispecific Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific CD Targeted Bispecific Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CD Targeted Bispecific Antibody Market Size (2020-2031)
9.2 Latin America CD Targeted Bispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CD Targeted Bispecific Antibody Market Size by Country (2020-2025)
9.4 Latin America CD Targeted Bispecific Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CD Targeted Bispecific Antibody Market Size (2020-2031)
10.2 Middle East & Africa CD Targeted Bispecific Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CD Targeted Bispecific Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa CD Targeted Bispecific Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aptevo Therapeutics
11.1.1 Aptevo Therapeutics Company Details
11.1.2 Aptevo Therapeutics Business Overview
11.1.3 Aptevo Therapeutics CD Targeted Bispecific Antibody Introduction
11.1.4 Aptevo Therapeutics Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.1.5 Aptevo Therapeutics Recent Development
11.2 Affimed Gmbh
11.2.1 Affimed Gmbh Company Details
11.2.2 Affimed Gmbh Business Overview
11.2.3 Affimed Gmbh CD Targeted Bispecific Antibody Introduction
11.2.4 Affimed Gmbh Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.2.5 Affimed Gmbh Recent Development
11.3 Sutro Biopharma
11.3.1 Sutro Biopharma Company Details
11.3.2 Sutro Biopharma Business Overview
11.3.3 Sutro Biopharma CD Targeted Bispecific Antibody Introduction
11.3.4 Sutro Biopharma Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.3.5 Sutro Biopharma Recent Development
11.4 Igm Biosciences
11.4.1 Igm Biosciences Company Details
11.4.2 Igm Biosciences Business Overview
11.4.3 Igm Biosciences CD Targeted Bispecific Antibody Introduction
11.4.4 Igm Biosciences Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.4.5 Igm Biosciences Recent Development
11.5 Xencor
11.5.1 Xencor Company Details
11.5.2 Xencor Business Overview
11.5.3 Xencor CD Targeted Bispecific Antibody Introduction
11.5.4 Xencor Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.5.5 Xencor Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen CD Targeted Bispecific Antibody Introduction
11.6.4 Amgen Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Genentech Usa
11.7.1 Genentech Usa Company Details
11.7.2 Genentech Usa Business Overview
11.7.3 Genentech Usa CD Targeted Bispecific Antibody Introduction
11.7.4 Genentech Usa Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.7.5 Genentech Usa Recent Development
11.8 Astella Pharma
11.8.1 Astella Pharma Company Details
11.8.2 Astella Pharma Business Overview
11.8.3 Astella Pharma CD Targeted Bispecific Antibody Introduction
11.8.4 Astella Pharma Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.8.5 Astella Pharma Recent Development
11.9 Ben Kang Biopharmaceutical (Shenzhen)
11.9.1 Ben Kang Biopharmaceutical (Shenzhen) Company Details
11.9.2 Ben Kang Biopharmaceutical (Shenzhen) Business Overview
11.9.3 Ben Kang Biopharmaceutical (Shenzhen) CD Targeted Bispecific Antibody Introduction
11.9.4 Ben Kang Biopharmaceutical (Shenzhen) Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.9.5 Ben Kang Biopharmaceutical (Shenzhen) Recent Development
11.10 Merus
11.10.1 Merus Company Details
11.10.2 Merus Business Overview
11.10.3 Merus CD Targeted Bispecific Antibody Introduction
11.10.4 Merus Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.10.5 Merus Recent Development
11.11 Regeneron Pharmaceuticals
11.11.1 Regeneron Pharmaceuticals Company Details
11.11.2 Regeneron Pharmaceuticals Business Overview
11.11.3 Regeneron Pharmaceuticals CD Targeted Bispecific Antibody Introduction
11.11.4 Regeneron Pharmaceuticals Revenue in CD Targeted Bispecific Antibody Business (2020-2025)
11.11.5 Regeneron Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CD Targeted Bispecific Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CD3
Table 3. Key Players of CD20
Table 4. Key Players of CD40
Table 5. Key Players of Others
Table 6. Global CD Targeted Bispecific Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global CD Targeted Bispecific Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global CD Targeted Bispecific Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global CD Targeted Bispecific Antibody Market Share by Region (2020-2025)
Table 10. Global CD Targeted Bispecific Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global CD Targeted Bispecific Antibody Market Share by Region (2026-2031)
Table 12. CD Targeted Bispecific Antibody Market Trends
Table 13. CD Targeted Bispecific Antibody Market Drivers
Table 14. CD Targeted Bispecific Antibody Market Challenges
Table 15. CD Targeted Bispecific Antibody Market Restraints
Table 16. Global CD Targeted Bispecific Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global CD Targeted Bispecific Antibody Market Share by Players (2020-2025)
Table 18. Global Top CD Targeted Bispecific Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD Targeted Bispecific Antibody as of 2024)
Table 19. Ranking of Global Top CD Targeted Bispecific Antibody Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by CD Targeted Bispecific Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of CD Targeted Bispecific Antibody, Headquarters and Area Served
Table 22. Global Key Players of CD Targeted Bispecific Antibody, Product and Application
Table 23. Global Key Players of CD Targeted Bispecific Antibody, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CD Targeted Bispecific Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global CD Targeted Bispecific Antibody Revenue Market Share by Type (2020-2025)
Table 27. Global CD Targeted Bispecific Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global CD Targeted Bispecific Antibody Revenue Market Share by Type (2026-2031)
Table 29. Global CD Targeted Bispecific Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global CD Targeted Bispecific Antibody Revenue Market Share by Application (2020-2025)
Table 31. Global CD Targeted Bispecific Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global CD Targeted Bispecific Antibody Revenue Market Share by Application (2026-2031)
Table 33. North America CD Targeted Bispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America CD Targeted Bispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America CD Targeted Bispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe CD Targeted Bispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe CD Targeted Bispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe CD Targeted Bispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific CD Targeted Bispecific Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific CD Targeted Bispecific Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific CD Targeted Bispecific Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America CD Targeted Bispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America CD Targeted Bispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America CD Targeted Bispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa CD Targeted Bispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa CD Targeted Bispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa CD Targeted Bispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 48. Aptevo Therapeutics Company Details
Table 49. Aptevo Therapeutics Business Overview
Table 50. Aptevo Therapeutics CD Targeted Bispecific Antibody Product
Table 51. Aptevo Therapeutics Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 52. Aptevo Therapeutics Recent Development
Table 53. Affimed Gmbh Company Details
Table 54. Affimed Gmbh Business Overview
Table 55. Affimed Gmbh CD Targeted Bispecific Antibody Product
Table 56. Affimed Gmbh Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 57. Affimed Gmbh Recent Development
Table 58. Sutro Biopharma Company Details
Table 59. Sutro Biopharma Business Overview
Table 60. Sutro Biopharma CD Targeted Bispecific Antibody Product
Table 61. Sutro Biopharma Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 62. Sutro Biopharma Recent Development
Table 63. Igm Biosciences Company Details
Table 64. Igm Biosciences Business Overview
Table 65. Igm Biosciences CD Targeted Bispecific Antibody Product
Table 66. Igm Biosciences Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 67. Igm Biosciences Recent Development
Table 68. Xencor Company Details
Table 69. Xencor Business Overview
Table 70. Xencor CD Targeted Bispecific Antibody Product
Table 71. Xencor Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 72. Xencor Recent Development
Table 73. Amgen Company Details
Table 74. Amgen Business Overview
Table 75. Amgen CD Targeted Bispecific Antibody Product
Table 76. Amgen Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 77. Amgen Recent Development
Table 78. Genentech Usa Company Details
Table 79. Genentech Usa Business Overview
Table 80. Genentech Usa CD Targeted Bispecific Antibody Product
Table 81. Genentech Usa Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 82. Genentech Usa Recent Development
Table 83. Astella Pharma Company Details
Table 84. Astella Pharma Business Overview
Table 85. Astella Pharma CD Targeted Bispecific Antibody Product
Table 86. Astella Pharma Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 87. Astella Pharma Recent Development
Table 88. Ben Kang Biopharmaceutical (Shenzhen) Company Details
Table 89. Ben Kang Biopharmaceutical (Shenzhen) Business Overview
Table 90. Ben Kang Biopharmaceutical (Shenzhen) CD Targeted Bispecific Antibody Product
Table 91. Ben Kang Biopharmaceutical (Shenzhen) Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 92. Ben Kang Biopharmaceutical (Shenzhen) Recent Development
Table 93. Merus Company Details
Table 94. Merus Business Overview
Table 95. Merus CD Targeted Bispecific Antibody Product
Table 96. Merus Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 97. Merus Recent Development
Table 98. Regeneron Pharmaceuticals Company Details
Table 99. Regeneron Pharmaceuticals Business Overview
Table 100. Regeneron Pharmaceuticals CD Targeted Bispecific Antibody Product
Table 101. Regeneron Pharmaceuticals Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 102. Regeneron Pharmaceuticals Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. CD Targeted Bispecific Antibody Picture
Figure 2. Global CD Targeted Bispecific Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD Targeted Bispecific Antibody Market Share by Type: 2024 VS 2031
Figure 4. CD3 Features
Figure 5. CD20 Features
Figure 6. CD40 Features
Figure 7. Others Features
Figure 8. Global CD Targeted Bispecific Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global CD Targeted Bispecific Antibody Market Share by Application: 2024 VS 2031
Figure 10. Biotechnology Case Studies
Figure 11. Laboratory Case Studies
Figure 12. Others Case Studies
Figure 13. CD Targeted Bispecific Antibody Report Years Considered
Figure 14. Global CD Targeted Bispecific Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global CD Targeted Bispecific Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global CD Targeted Bispecific Antibody Market Share by Region: 2024 VS 2031
Figure 17. Global CD Targeted Bispecific Antibody Market Share by Players in 2024
Figure 18. Global Top CD Targeted Bispecific Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD Targeted Bispecific Antibody as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by CD Targeted Bispecific Antibody Revenue in 2024
Figure 20. North America CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America CD Targeted Bispecific Antibody Market Share by Country (2020-2031)
Figure 22. United States CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe CD Targeted Bispecific Antibody Market Share by Country (2020-2031)
Figure 26. Germany CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific CD Targeted Bispecific Antibody Market Share by Region (2020-2031)
Figure 34. China CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America CD Targeted Bispecific Antibody Market Share by Country (2020-2031)
Figure 42. Mexico CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa CD Targeted Bispecific Antibody Market Share by Country (2020-2031)
Figure 46. Turkey CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Aptevo Therapeutics Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 50. Affimed Gmbh Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 51. Sutro Biopharma Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 52. Igm Biosciences Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 53. Xencor Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 54. Amgen Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 55. Genentech Usa Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 56. Astella Pharma Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 57. Ben Kang Biopharmaceutical (Shenzhen) Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 58. Merus Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 59. Regeneron Pharmaceuticals Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global CD Targeted Bispecific Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CD3
Table 3. Key Players of CD20
Table 4. Key Players of CD40
Table 5. Key Players of Others
Table 6. Global CD Targeted Bispecific Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global CD Targeted Bispecific Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global CD Targeted Bispecific Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global CD Targeted Bispecific Antibody Market Share by Region (2020-2025)
Table 10. Global CD Targeted Bispecific Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global CD Targeted Bispecific Antibody Market Share by Region (2026-2031)
Table 12. CD Targeted Bispecific Antibody Market Trends
Table 13. CD Targeted Bispecific Antibody Market Drivers
Table 14. CD Targeted Bispecific Antibody Market Challenges
Table 15. CD Targeted Bispecific Antibody Market Restraints
Table 16. Global CD Targeted Bispecific Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global CD Targeted Bispecific Antibody Market Share by Players (2020-2025)
Table 18. Global Top CD Targeted Bispecific Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD Targeted Bispecific Antibody as of 2024)
Table 19. Ranking of Global Top CD Targeted Bispecific Antibody Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by CD Targeted Bispecific Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of CD Targeted Bispecific Antibody, Headquarters and Area Served
Table 22. Global Key Players of CD Targeted Bispecific Antibody, Product and Application
Table 23. Global Key Players of CD Targeted Bispecific Antibody, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CD Targeted Bispecific Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global CD Targeted Bispecific Antibody Revenue Market Share by Type (2020-2025)
Table 27. Global CD Targeted Bispecific Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global CD Targeted Bispecific Antibody Revenue Market Share by Type (2026-2031)
Table 29. Global CD Targeted Bispecific Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global CD Targeted Bispecific Antibody Revenue Market Share by Application (2020-2025)
Table 31. Global CD Targeted Bispecific Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global CD Targeted Bispecific Antibody Revenue Market Share by Application (2026-2031)
Table 33. North America CD Targeted Bispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America CD Targeted Bispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America CD Targeted Bispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe CD Targeted Bispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe CD Targeted Bispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe CD Targeted Bispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific CD Targeted Bispecific Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific CD Targeted Bispecific Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific CD Targeted Bispecific Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America CD Targeted Bispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America CD Targeted Bispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America CD Targeted Bispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa CD Targeted Bispecific Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa CD Targeted Bispecific Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa CD Targeted Bispecific Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 48. Aptevo Therapeutics Company Details
Table 49. Aptevo Therapeutics Business Overview
Table 50. Aptevo Therapeutics CD Targeted Bispecific Antibody Product
Table 51. Aptevo Therapeutics Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 52. Aptevo Therapeutics Recent Development
Table 53. Affimed Gmbh Company Details
Table 54. Affimed Gmbh Business Overview
Table 55. Affimed Gmbh CD Targeted Bispecific Antibody Product
Table 56. Affimed Gmbh Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 57. Affimed Gmbh Recent Development
Table 58. Sutro Biopharma Company Details
Table 59. Sutro Biopharma Business Overview
Table 60. Sutro Biopharma CD Targeted Bispecific Antibody Product
Table 61. Sutro Biopharma Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 62. Sutro Biopharma Recent Development
Table 63. Igm Biosciences Company Details
Table 64. Igm Biosciences Business Overview
Table 65. Igm Biosciences CD Targeted Bispecific Antibody Product
Table 66. Igm Biosciences Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 67. Igm Biosciences Recent Development
Table 68. Xencor Company Details
Table 69. Xencor Business Overview
Table 70. Xencor CD Targeted Bispecific Antibody Product
Table 71. Xencor Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 72. Xencor Recent Development
Table 73. Amgen Company Details
Table 74. Amgen Business Overview
Table 75. Amgen CD Targeted Bispecific Antibody Product
Table 76. Amgen Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 77. Amgen Recent Development
Table 78. Genentech Usa Company Details
Table 79. Genentech Usa Business Overview
Table 80. Genentech Usa CD Targeted Bispecific Antibody Product
Table 81. Genentech Usa Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 82. Genentech Usa Recent Development
Table 83. Astella Pharma Company Details
Table 84. Astella Pharma Business Overview
Table 85. Astella Pharma CD Targeted Bispecific Antibody Product
Table 86. Astella Pharma Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 87. Astella Pharma Recent Development
Table 88. Ben Kang Biopharmaceutical (Shenzhen) Company Details
Table 89. Ben Kang Biopharmaceutical (Shenzhen) Business Overview
Table 90. Ben Kang Biopharmaceutical (Shenzhen) CD Targeted Bispecific Antibody Product
Table 91. Ben Kang Biopharmaceutical (Shenzhen) Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 92. Ben Kang Biopharmaceutical (Shenzhen) Recent Development
Table 93. Merus Company Details
Table 94. Merus Business Overview
Table 95. Merus CD Targeted Bispecific Antibody Product
Table 96. Merus Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 97. Merus Recent Development
Table 98. Regeneron Pharmaceuticals Company Details
Table 99. Regeneron Pharmaceuticals Business Overview
Table 100. Regeneron Pharmaceuticals CD Targeted Bispecific Antibody Product
Table 101. Regeneron Pharmaceuticals Revenue in CD Targeted Bispecific Antibody Business (2020-2025) & (US$ Million)
Table 102. Regeneron Pharmaceuticals Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. CD Targeted Bispecific Antibody Picture
Figure 2. Global CD Targeted Bispecific Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CD Targeted Bispecific Antibody Market Share by Type: 2024 VS 2031
Figure 4. CD3 Features
Figure 5. CD20 Features
Figure 6. CD40 Features
Figure 7. Others Features
Figure 8. Global CD Targeted Bispecific Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global CD Targeted Bispecific Antibody Market Share by Application: 2024 VS 2031
Figure 10. Biotechnology Case Studies
Figure 11. Laboratory Case Studies
Figure 12. Others Case Studies
Figure 13. CD Targeted Bispecific Antibody Report Years Considered
Figure 14. Global CD Targeted Bispecific Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global CD Targeted Bispecific Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global CD Targeted Bispecific Antibody Market Share by Region: 2024 VS 2031
Figure 17. Global CD Targeted Bispecific Antibody Market Share by Players in 2024
Figure 18. Global Top CD Targeted Bispecific Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD Targeted Bispecific Antibody as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by CD Targeted Bispecific Antibody Revenue in 2024
Figure 20. North America CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America CD Targeted Bispecific Antibody Market Share by Country (2020-2031)
Figure 22. United States CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe CD Targeted Bispecific Antibody Market Share by Country (2020-2031)
Figure 26. Germany CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific CD Targeted Bispecific Antibody Market Share by Region (2020-2031)
Figure 34. China CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America CD Targeted Bispecific Antibody Market Share by Country (2020-2031)
Figure 42. Mexico CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa CD Targeted Bispecific Antibody Market Share by Country (2020-2031)
Figure 46. Turkey CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE CD Targeted Bispecific Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Aptevo Therapeutics Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 50. Affimed Gmbh Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 51. Sutro Biopharma Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 52. Igm Biosciences Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 53. Xencor Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 54. Amgen Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 55. Genentech Usa Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 56. Astella Pharma Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 57. Ben Kang Biopharmaceutical (Shenzhen) Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 58. Merus Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 59. Regeneron Pharmaceuticals Revenue Growth Rate in CD Targeted Bispecific Antibody Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Krypton Flash Lamp Market Research Report 2025
May 12, 25
Global IR Halogen Lamp Market Research Report 2025
May 12, 25
Global Halogen IR Lamp Market Research Report 2025
May 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232